AG
LXRX icon

Artal Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$129M Hold
136,180,481
13.91% 2
2025
Q1
$62.6M Hold
136,180,481
7.08% 2
2024
Q4
$101M Hold
136,180,481
8.59% 2
2024
Q3
$214M Sell
136,180,481
-38,918,903
-22% -$61.1M 8.98% 2
2024
Q2
$294M Buy
175,099,384
+57,546,100
+49% +$96.7M 7.5% 2
2024
Q1
$282M Hold
117,553,284
7.19% 2
2023
Q4
$180M Hold
117,553,284
5.98% 3
2023
Q3
$128M Hold
117,553,284
5.49% 2
2023
Q2
$269M Buy
117,553,284
+27,775,050
+31% +$63.6M 8.34% 2
2023
Q1
$218M Hold
89,778,234
12.96% 1
2022
Q4
$171M Hold
89,778,234
9.57% 1
2022
Q3
$215M Buy
89,778,234
+18,599,870
+26% +$44.6M 9.2% 1
2022
Q2
$132M Hold
71,178,364
7.07% 2
2022
Q1
$149M Hold
71,178,364
6.23% 3
2021
Q4
$280M Hold
71,178,364
7.61% 1
2021
Q3
$342M Hold
71,178,364
7.66% 1
2021
Q2
$327M Hold
71,178,364
6.63% 2
2021
Q1
$418M Hold
71,178,364
7.38% 2
2020
Q4
$243M Buy
71,178,364
+10,937,500
+18% +$37.4M 5.23% 4
2020
Q3
$86.7M Hold
60,240,864
2.11% 8
2020
Q2
$120M Hold
60,240,864
3.36% 6
2020
Q1
$117M Hold
60,240,864
4.96% 5
2019
Q4
$250M Hold
60,240,864
9.66% 2
2019
Q3
$181M Hold
60,240,864
7.27% 2
2019
Q2
$379M Hold
60,240,864
15.32% 1
2019
Q1
$335M Hold
60,240,864
13.68% 1
2018
Q4
$400M Hold
60,240,864
14.82% 2
2018
Q3
$643M Hold
60,240,864
16.72% 2
2018
Q2
$723M Buy
60,240,864
+1,966,214
+3% +$23.6M 15.36% 2
2018
Q1
$499M Hold
58,274,650
6.25% 3
2017
Q4
$576M Buy
58,274,650
+756,673
+1% +$7.48M 8.68% 3
2017
Q3
$707M Hold
57,517,977
12.18% 3
2017
Q2
$946M Hold
57,517,977
16.53% 3
2017
Q1
$825M Hold
57,517,977
18.31% 2
2016
Q4
$795M Hold
57,517,977
17.66% 2
2016
Q3
$1.04B Hold
57,517,977
20.58% 2
2016
Q2
$825M Hold
57,517,977
17.04% 2
2016
Q1
$687M Hold
57,517,977
13.41% 2
2015
Q4
$766M Sell
57,517,977
-1
-0% -$13 14.37% 2
2015
Q3
$618M Hold
57,517,978
13.8% 2
2015
Q2
$463M Sell
57,517,978
-345,107,888
-86% -$2.78B 19.93% 1
2015
Q1
$378M Hold
402,625,866
17.5% 1
2014
Q4
$366M Buy
402,625,866
+149,253,731
+59% +$136M 12.86% 2
2014
Q3
$357M Hold
253,372,135
13.15% 2
2014
Q2
$408M Hold
253,372,135
16.49% 2
2014
Q1
$438M Hold
253,372,135
15.87% 2
2013
Q4
$456M Hold
253,372,135
16.36% 2
2013
Q3
$603M Hold
253,372,135
19.63% 2
2013
Q2
$550M Buy
+253,372,135
New +$550M 17.3% 2